GTP14564|CAS 34823-86-4|DC Chemicals

Cas No.:	34823-86-4
Chemical Name:	GTP 14564
Synonyms:	GTP-14564;3-phenyl-1H-[1]benzofuro[3,2-c]pyrazole;GTP 14564;3-Phenyl-1H-benzofuro[3,2-c]pyrazole;3-Phenyl-1H-benzofuro<3,2-c>pyrazol;CS-0032847;GTP14564;NCGC00159539-01;GTP-14564 - CAS 34823-86-4;GTPL5982;3-phenyl-2h-benzofuro[3,2-c]pyrazole;HMS3677E13;J-019773;CHEBI:92300;HY-110026;1-Phenyl-3-H-8-oxa-2,3-diaza-cyclopenta[a]inden;NCGC00159539-02;BRD-K16664969-001-02-5;DTXSID10188363;BDBM50375646;5-phenyl-7-oxa-3,4-diazatricyclo[6.4.0.0?,?]dodeca-1(12),2(6),4,8,10-pentaene;5-phenyl-7-oxa-3,4-diazatricyclo[6.4.0.0^{2,6}]dodeca-1(12),2(6),4,8,10-pentaene;BRD-K16664969-001-01-7;34823-86-4;CHEMBL406375;AI-204/33265070;3-Phenyl-1H-benzofuro(3,2-c)pyrazole;CCG-206757;HSCI1_000176;HMS3413E13;SCHEMBL2550165;HMS3229E17;AKOS024456938;Q27077928;HMS3268J15;5-phenyl-7-oxa-3,4-diazatricyclo(6.4.0.0^(2,6))dodeca-1(12),2(6),4,8,10-pentaene;DA-53771;5-phenyl-7-oxa-3,4-diazatricyclo[6.4.0.0(2),?]dodeca-1(8),2(6),4,9,11-pentaene;BRD-K16664969-001-03-3;SDCCGSBI-0086680.P003;TS-09594;DTXCID40110854;G72353
SMILES:	O1C2C=CC=CC=2C2=C1C(C1C=CC=CC=1)=NN2
Formula:	C₁₅H₁₀N₂O
M.Wt:	234.25270318985
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Cat. No.	Product name	Field of application
DC31074	Isopropyl myristate	Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC75868	AZ14133346	AZ14133346 (compound 36) is a potent and selective inhibitor of EGFR Exon20 insertions, with the IC50 of 85 nM. AZ14133346 plays an important role in cancer research.
DC75865	TI17	TI17 represents a novel class of targeted anticancer agents that specifically disrupt DNA damage repair mechanisms in malignant cells.
DC75816	Nisoxetine	Nisoxetine acts as a highly selective and potent noradrenaline transporter (NET) antagonist, exhibiting a binding affinity (Kd) of 0.76 nM. In addition to its antidepressant properties, nisoxetine functions as a local anesthetic by inhibiting voltage-gated sodium channels. This dual pharmacological activity makes it a compound of interest for both neurological and pain management research.
DC75641	GENZ-644282 TFA salt	Genz-644282, also known as SAR402674, is a non-camptothecin inhibitor of topoisomerase I with potential antineoplastic activity. Topoisomerase I inhibitor Genz-644282 binds to and inhibits the enzyme topoisomerase I, which may result in the inhibition of repair of single-strand DNA breaks, DNA replication, and tumor cell growth in susceptible tumor cell populations.
DC75325	PSMA-617 TFA	PSMA-617, also know as vipivotide tetraxetan, is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer. PSMA617 possesses a small peptide, which was designed to target prostate-specific membrane antigen (PSMA). PSMA617 demonstrates high radiolytic stability for at least 72 h. PSMA617 has high inhibition potency (equilibrium dissociation constant Ki=2.34±2.94 nM on LNCaP; Ki=0.37±0.21 nM enzymatically determined). 177 Lu-PSMA-617 offers a potential additional life-prolonging treatment option for men with mCRPC.
DC75202	Fosaprepitant free acid	Fosaprepitant, also known as MK0517, is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment. Fosaprepitant is a weak inhibitor of CYP3A4, and aprepitant, the active moiety, is a substrate, inhibitor, and inducer of CYP3A4
DC74748	O4I4	O4I4 (compound 23) is a OCT4-inducing compound with metabolical stability.
DC74684	ZH8667	ZH8667 is a trace amine-associated receptor 1 (TAAR1)–Gs agonist.
DC74646	EB-PSMA-617	EB-PSMA-617 is an Evans blue-modified prostate-specific membrane antigen (PSMA) 617 ligand for making 177Lu-EB-PSMA, which is potential useful for Metastatic Castration-Resistant Prostate Cancer.